Encephalopathy Archives - Insights

Updates Streamline Autoimmune Neurology Testing: Anastasia Zekeridou, M.D., Ph.D.

Barbara J. Toman — Tue, 11 Jun 2024 13:00:00 +0000

Anastasia Zekeridou, M.D., Ph.D., explains how Mayo Clinic Laboratories' updated panels and methodology boost the accuracy and efficiency of testing for three autoimmune neurology biomarkers. Early diagnosis is key to managing debilitating conditions associated with these antibodies.

The post Updates Streamline Autoimmune Neurology Testing: Anastasia Zekeridou, M.D., Ph.D. appeared first on Insights.

Tests Aid Diagnosis of Cancer-Associated Neurological Disorders: Divyanshu Dubey, M.B.B.S.

Barbara J. Toman — Tue, 04 Jun 2024 13:00:00 +0000

Divyanshu Dubey, M.B.B.S., explains how Mayo Clinic Laboratories' unique PDE10A and TRIM46 tests facilitate the management of central nervous system disorders triggered by cancers. Early diagnosis and treatment are important for managing disabling neurological symptoms and malignancy.

The post Tests Aid Diagnosis of Cancer-Associated Neurological Disorders: Divyanshu Dubey, M.B.B.S. appeared first on Insights.

Predictors to Direct Neural Antibody Testing in Autoimmune Encephalitis/Epilepsy

MCL Education — Mon, 11 Sep 2023 12:00:00 +0000

In this “Hot Topic,” Divyanshu Dubey, M.B.B.S., associate professor of laboratory medicine and pathology and neurology at Mayo Clinic, discusses various clinical and paraclinical features of autoimmune encephalitis, autoimmune seizures, and epilepsy.

The post Predictors to Direct Neural Antibody Testing in Autoimmune Encephalitis/Epilepsy appeared first on Insights.

Test detects autoimmune neurology disorders linked to cancer: Sean Pittock, M.D.

Barbara J. Toman — Tue, 25 Apr 2023 13:00:00 +0000

Sean Pittock, M.D., explains how Mayo Clinic Laboratories' novel Ma2 test aids diagnosis of autoimmune neurology disorders that are often caused by underlying cancer. Rapid diagnosis is key to preventing significant disability and disease.

The post Test detects autoimmune neurology disorders linked to cancer: Sean Pittock, M.D. appeared first on Insights.

Autoimmune Encephalitis Misdiagnosis

MCL Education — Mon, 20 Feb 2023 11:00:00 +0000

In this month's "Hot Topic," Eoin Flanagan, M.B., B. Ch., discusses the important issue of autoimmune encephalitis misdiagnosis and identifies red flags that be useful in clinical practice to suggest alternative diagnoses and highlight antibodies that sometimes cause confusion.

The post Autoimmune Encephalitis Misdiagnosis appeared first on Insights.

Back from the brink: Sheila Lewis

Mayo Clinic Laboratories — Mon, 03 Jan 2022 13:45:00 +0000

Mayo Clinic Laboratories’ comprehensive approach to targeted antibody testing played a crucial and lifesaving role in moving Sheila Lewis to recovery from autoimmune encephalitis.

The post Back from the brink: Sheila Lewis appeared first on Insights.

Neuroimmunology: Updates and antibody test utilization

MCL Education — Mon, 24 May 2021 06:00:00 +0000

In this month’s “Hot Topic,” Andrew McKeon, M.B., B.Ch., M.D., reviews the use of neurological phenotype-based evaluations, the move away from the paraneoplastic evaluation, and upcoming changes to test profiles.

The post Neuroimmunology: Updates and antibody test utilization appeared first on Insights.

Nailing the Suspect: The Prevalence of Autoimmune Encephalitis Compared with Infectious Encephalitis

Barbara J. Toman — Sun, 29 Apr 2018 21:00:23 +0000

For people with encephalitis, rapid treatment of their acute brain inflammation is critical for avoiding devastating physical and cognitive deficits. But appropriate treatment requires identifying the culprit causing the symptoms.

The post Nailing the Suspect: The Prevalence of Autoimmune Encephalitis Compared with Infectious Encephalitis appeared first on Insights.

Beyond the Test Result: Greg Widseth

Mayo Clinic Laboratories — Tue, 20 Dec 2016 19:31:06 +0000

Greg Widseth was suddenly hit by a rare disease that prompted his immune system to attack his brain cells, resulting in as many as 60 seizures a day. Special blood and spinal fluid tests developed by Mayo Medical Laboratories confirmed that Widseth had antibodies known to target certain brain cells.

The post Beyond the Test Result: Greg Widseth appeared first on Insights.